55
https://pubmed.ncbi.nlm.nih.gov/38117405
This study explores the use of cell-derived biomimetic nanoparticles to deliver drugs targeted at Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) treatment, aiming to overcome current drug delivery challenges and improve treatment outcomes.